METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer-Reference-Cited by-同舟云学术

METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer

Published:2017-01 Issue:1 Volume:71 Page:81-92
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Padhani Anwar R.,Lecouvet Frederic E.,Tunariu Nina,Koh Dow-Mu,De Keyzer Frederik,Collins David J.,Sala Evis,Schlemmer Heinz Peter,Petralia Giuseppe,Vargas H. Alberto,Fanti Stefano,Tombal H. Bertrand,de Bono Johann

Publisher

Elsevier BV

Subject

Urology

Reference44 articles.

1. Progress in emerging therapies for advanced prostate cancer;Oudard;Cancer Treat Rev,2013

2. Targeting bone metastases in prostate cancer: Improving clinical outcome;Body;Nat Rev Urol,2015

3. Castration-resistant prostate cancer: from new pathophysiology to new treatment;Sridhar;Eur Urol,2014

4. Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel;Fitzpatrick;Eur J Cancer,2014

5. Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015;Gillessen;Ann Oncol,2015

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse;Abdominal Radiology;2024-09-10

2. High-performing, Accessible, and Affordable Imaging in Metastatic Prostate Cancer: Is Whole-body Magnetic Resonance Imaging the Answer?;European Urology;2024-09

3. Reply to Anwar R. Padhani, Frederic LeCouvet, Giuseppe Petralia, and Dow-Mu Koh’s Letter to the Editor re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016;European Urology;2024-09

4. Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide;European Urology;2024-09

5. Re: Alonso Garcia-Ruiz, Carlos Macarro, Francesca Zacchi, et al. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.016;European Urology;2024-09